Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-12,057
Closed -$424K 602
2016
Q1
$424K Sell
12,057
-20,081
-62% -$630K 0.01% 501
2015
Q4
$1.04M Sell
32,138
-1,117
-3% -$40.2K 0.01% 387
2015
Q3
$1.15M Sell
33,255
-8,478
-20% -$326K 0.02% 349
2015
Q2
$1.68M Sell
41,733
-20,367
-33% -$730K 0.02% 303
2015
Q1
$2.25M Sell
62,100
-26,857
-30% -$875K 0.03% 248
2014
Q4
$2.99M Buy
88,957
+21,410
+32% +$701K 0.04% 217
2014
Q3
$2.25M Buy
+67,547
New +$2.48M 0.03% 247

Other funds holding AGX

Analytic Investors's AGX Position: Q2 2016 in Review

Analytic Investors sold out of Argan (AGX) in Q2 2016, closing a stake of 12,057 shares — an estimated $424K sold.

Analytic Investors first reported a position in AGX in Q3 2014 and held it in 7 quarters. The position peaked at $2.99M in Q4 2014. 136 funds tracked by Wall St. Rank hold AGX as of Q2 2016.

  • Analytic Investors reported no remaining Argan position as of Q2 2016 after selling out during the quarter.
  • Analytic Investors sold 12,057 Argan shares in Q2 2016, an estimated $424K.
  • Analytic Investors first reported a position in Argan in Q3 2014 and held it in 7 quarters.
  • Analytic Investors's Argan position peaked at $2.99M in Q4 2014.
  • 136 funds tracked by Wall St. Rank held Argan as of Q2 2016.

Based on Analytic Investors's 13F filing for Q2 2016, filed 11 Aug 2016.